These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9210004)

  • 41. Identification and eradication of Helicobacter pylori in an isolated patient population.
    Myers D
    Mil Med; 1997 Jul; 162(7):507-9. PubMed ID: 9232984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Helicobacter pylori infection: a review.
    Blecker U; Gold BD
    Pediatr Infect Dis J; 1997 Apr; 16(4):391-9. PubMed ID: 9109142
    [No Abstract]   [Full Text] [Related]  

  • 43. Helicobacter pylori eradication treatment reduces the severity of rosacea.
    Utaş S; Ozbakir O; Turasan A; Utaş C
    J Am Acad Dermatol; 1999 Mar; 40(3):433-5. PubMed ID: 10071314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.
    Marcus EA; Sachs G; Scott DR
    Aliment Pharmacol Ther; 2015 Oct; 42(7):922-33. PubMed ID: 26238858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Healing of chronic antral gastritis: effect of sucralfate and colloidal bismuth subcitrate.
    Kumar M; Yachha SK; Aggarwal R; Shukla S; Pandey R; Prasad KN; Ayyagari A; Naik SR
    Indian J Gastroenterol; 1996 Jul; 15(3):90-3. PubMed ID: 8840633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mode of action of colloidal bismuth subcitrate.
    Lee SP
    Scand J Gastroenterol Suppl; 1991; 185():1-6. PubMed ID: 1957120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy.
    Phillips RH; Whitehead MW; Lacey S; Champion M; Thompson RP; Powell JJ
    Helicobacter; 2000 Sep; 5(3):176-82. PubMed ID: 10971684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Helicobacter pylori.
    Seifrit B
    AORN J; 1997 Mar; 65(3):614-6, 619-20. PubMed ID: 9061156
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficiency of Moxifloxacin in the Treatment of Helicobacter pylori Infection.
    Altun B; Ozturk K
    Gut Liver; 2015 Nov; 9(6):809-10. PubMed ID: 26087796
    [No Abstract]   [Full Text] [Related]  

  • 50. Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study.
    Chiang TH; Chen CC; Tseng PH; Liou JM; Wu MS; Shun CT; Lee YC; Graham DY
    Helicobacter; 2021 Jun; 26(3):e12801. PubMed ID: 33740276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
    Miller JP
    Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Helicobacter pylori infection on colloidal bismuth subcitrate concentration in gastric mucus.
    Muñoz DJ; Tasman-Jones C; Pybus J
    Gut; 1992 May; 33(5):592-6. PubMed ID: 1377152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of ranitidine and metronidazole on 1gG activity of patients with Helicobacter pylori infection.
    Konorev MR
    Int J Antimicrob Agents; 1998 Aug; 10(3):249-50. PubMed ID: 9832287
    [No Abstract]   [Full Text] [Related]  

  • 54. Reflections on gastric ulcer disease.
    Tytgat GN
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):333-4. PubMed ID: 8781900
    [No Abstract]   [Full Text] [Related]  

  • 55. Helicobacter pylori infection in children with recurrent abdominal pain.
    Wewer V; Christiansen KM; Andersen LP; Henriksen FW; Hansen JP; Tvede M; Krasilnikoff PA
    Acta Paediatr; 1994 Dec; 83(12):1276-81. PubMed ID: 7734870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevention of duodenal ulcer recurrence. A new prospect].
    Soulé JC
    Presse Med; 1991 Mar; 20(10):465-70. PubMed ID: 1673786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colloidal bismuth subcitrate and omeprazole inhibit alcohol dehydrogenase mediated acetaldehyde production by Helicobacter pylori.
    Roine RP; Salmela KS; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Life Sci; 1992; 51(21):PL195-200. PubMed ID: 1435071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treating Helicobacter pylori--the best is yet to come?
    Harris A; Misiewicz JJ
    Gut; 1996 Dec; 39(6):781-3. PubMed ID: 9038656
    [No Abstract]   [Full Text] [Related]  

  • 59. Halitosis and Helicobacter pylori. A possible link?
    Tiomny E; Arber N; Moshkowitz M; Peled Y; Gilat T
    J Clin Gastroenterol; 1992 Oct; 15(3):236-7. PubMed ID: 1479169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Anti-secretory agents modify the gastric localization of Helicobacter pylori].
    Zaterka S
    Arq Gastroenterol; 2001; 38(1):1-2. PubMed ID: 11582958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.